IPOs & Markets
Fosun reorganised its businesses in 2016, creating Fosun Tourism Group and paving the way for the latter's listing plan.
Meituan was valued at around $30 billion in a fundraising round late last year.
At least 10 more mostly Chinese biotechs plan to go public in the city this year, with some even dropping plans for U.S. share sales in favour of lis
Canaan and Ebang filed plans for floats in Hong Kong, while Bitmain is expected to file its plans next month to raise at least $3 billion
The biopharmaceutical firm raised $172 million from its Nasdaq IPO in September 2017.
The company is the world's second largest lithium producer by sales.
Sany’s advisers have reached out to firms Bain Capital, Carlyle Group, CVC Capital Partners and KKR & Co for the deal.
The company raised $133 million in December in its series D fundraising round.
Babytree is targeting a valuation of $3-5 billion.
The fund will seek PE, late-stage investment opportunities in tech, particularly in strategic sectors such as AI.
© Copyright DEALSTREETASIA 2014-2019 All rights reserved.
Forgot your password?
We will never share your information with third parties.
Already have an account? Sign in here
If you don’t already have an account click the button below to create your account.
Unlock your competitive advantage in a
rapidly evolving landscape. Our packages
come with exclusive access to archive
content, data, discount on summit tickets & more.
Be a part of our growing community now.